Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
08/01/2023 | 26.01% | Stephens & Co. | → $18 | Reiterates | Equal-Weight → Equal-Weight |
07/11/2023 | 19.01% | Jefferies | $15 → $17 | Maintains | Buy |
07/10/2023 | — | Loop Capital | Downgrades | Buy → Hold | |
04/26/2023 | -16% | Truist Securities | $10 → $12 | Maintains | Hold |
04/25/2023 | 26.01% | Stephens & Co. | → $18 | Reiterates | → Equal-Weight |
04/13/2023 | -45.4% | B of A Securities | $6.5 → $7.8 | Maintains | Underperform |
03/06/2023 | 5.01% | Loop Capital | $20 → $15 | Maintains | Buy |
03/02/2023 | 26.01% | Stephens & Co. | → $18 | Reiterates | → Equal-Weight |
10/24/2022 | -54.5% | B of A Securities | → $6.5 | Downgrades | Neutral → Underperform |
06/29/2022 | 33.01% | Stephens & Co. | $26 → $19 | Maintains | Equal-Weight |
04/27/2022 | 61.01% | B of A Securities | $24 → $23 | Maintains | Neutral |
12/02/2020 | 40.01% | B of A Securities | → $20 | Initiates Coverage On | → Neutral |
12/02/2020 | — | Raymond James | Initiates Coverage On | → Market Perform | |
12/02/2020 | — | Keybanc | Initiates Coverage On | → Sector Weight | |
09/11/2020 | 390.02% | Truist Securities | $65 → $70 | Maintains | Buy |
09/11/2020 | 390.02% | Keybanc | $64 → $70 | Maintains | Overweight |
07/30/2020 | 390.02% | Jefferies | $63 → $70 | Maintains | Buy |
07/30/2020 | 355.02% | SunTrust Robinson Humphrey | $55 → $65 | Maintains | Buy |
07/30/2020 | 348.02% | Raymond James | $50 → $64 | Maintains | Strong Buy |
07/30/2020 | 348.02% | Keybanc | $60 → $64 | Maintains | Overweight |
06/10/2020 | 390.02% | Stifel | $49 → $70 | Maintains | Buy |
06/04/2020 | 250.02% | SunTrust Robinson Humphrey | $40 → $50 | Maintains | Buy |
05/08/2020 | 243.02% | Stifel | $29 → $49 | Maintains | Buy |
05/08/2020 | 180.01% | SunTrust Robinson Humphrey | $25 → $40 | Maintains | Buy |
05/08/2020 | 250.02% | Raymond James | $60 → $50 | Maintains | Strong Buy |
05/08/2020 | 285.02% | Keybanc | $66 → $55 | Maintains | Overweight |
04/07/2020 | 82.01% | Stephens & Co. | $68 → $26 | Downgrades | Overweight → Equal-Weight |
03/24/2020 | 103.01% | Stifel | $67 → $29 | Maintains | Buy |
02/21/2020 | 355.02% | SunTrust Robinson Humphrey | $70 → $65 | Maintains | Buy |
02/21/2020 | 320.02% | Raymond James | $80 → $60 | Maintains | Strong Buy |
02/21/2020 | 362.02% | Keybanc | $88 → $66 | Maintains | Overweight |
10/16/2019 | 460.03% | Raymond James | $72 → $80 | Maintains | Strong Buy |
09/26/2019 | 425.03% | B of A Securities | → $75 | Initiates Coverage On | → Buy |
07/26/2019 | 460.03% | Keybanc | $75 → $80 | Maintains | Overweight |
09/26/2018 | 355.02% | Stifel | $58 → $65 | Maintains | Buy |
09/20/2018 | 334.02% | Keybanc | $58 → $62 | Maintains | Overweight |
What is the target price for Aarons (AAN)?
The latest price target for Aarons (NYSE: AAN) was reported by Stephens & Co. on August 1, 2023. The analyst firm set a price target for $18.00 expecting AAN to rise to within 12 months (a possible 26.01% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Aarons (AAN)?
The latest analyst rating for Aarons (NYSE: AAN) was provided by Stephens & Co., and Aarons reiterated their equal-weight rating.
When is the next analyst rating going to be posted or updated for Aarons (AAN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aarons, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aarons was filed on August 1, 2023 so you should expect the next rating to be made available sometime around August 1, 2024.
Is the Analyst Rating Aarons (AAN) correct?
While ratings are subjective and will change, the latest Aarons (AAN) rating was a reiterated with a price target of $0.00 to $18.00. The current price Aarons (AAN) is trading at is $14.29, which is within the analyst's predicted range.